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CORRECTION
Correction to: A guide to writing 
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The original version of this article [1] unfortunately 
included a typo to a co-author’s name.
Author Carola Reinhard was erroneously presented as 
Carola Rheinard.
The correct author name is shown in the author list of 
this Correction and has already been updated in the orig-
inal article.
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